Treatment of Metabolic Syndrome patients in Thailand region using Shu Gan Tiao Shen needling method

Huayploo hospital0 个研究点目标入组 88 人开始时间: 2023年7月12日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•1. Symptom of metabolic syndrome correspond to IDF
•2. Age between 20 to 65 years, regardless of gender and weight.
•3. Absence of gastrointestinal disease such as diarrhea, constipation, etc. within 4 weeks.
•4. Consent to participate in the research project. and sign a letter of consent to participate in the research project

•1. Are at risk of coming into contact with a COVID19 infected person or cluster or have a history of traveling to the area with an epidemic.
•2. Have been diagnosed with depression or severe mental illness or have a tendency to committed suicide.
•3. Patients with heart disease, stroke, lung, liver, kidney, cancer patients, infectious disease patients.
•4. People who take medication to treat metabolic syndrome symptoms within 6 weeks or use Antibiotics, probiotics, prebiotics or internal gastrointestinal motility drugs 4 weeks
•5. Those who are unable to cooperate in the investigation and treatment.
•6. Women who are pregnant or breastfeeding.
•7. People who have a fever of 37.5 degrees Celsius or more with cough, runny nose, sore throat, shortness of breath.
•8. People who use drugs that act on the nervous system. and circulatory system.
•9. Have been treated with acupuncture before

发起方

Huayploo hospital